By Nick CoughlanPublished Feb 05, 2019 08:08:03Big data, which has become so ubiquitous in our daily lives, has changed the way that we shop, and it’s reshaping the world of medicine.
A big data firm like Target or Walgreens has been using analytics to sell more expensive and more sophisticated goods.
Big data is helping drugmakers make even more money.
But it’s also changing the way medicine is made.
Big data has become the new big pharma, as pharma giants like Pfizer, Johnson & Johnson, and others try to build the next big thing in the pharmaceutical industry.
And Big Pharma is taking notice.
In an exclusive interview with ESPN, CEO Dr. John C. Donahoe explains how Big Pharma and Big Data can be a big part of the solution.
“Big data is so ubiquitous,” Donahay said.
“It’s like a big blanket.
It’s just so easy to wrap your head around it.
It is so pervasive.”
Donahay says the next wave of pharmaceuticals will have to be driven by Big Data to drive the business.
And that’s why the Big Pharma giant is working with other companies and the government to help make Big Data available to all.
“We’re working to help the pharmaceuticals understand their data so that they can better leverage it and make better decisions,” Donahey said.
“The government has a lot of work to do to support Big Data and Big Business in the health care marketplace.
Big Data is not just about big data; Big Business is about big business.”
Big Pharma says Big Data helps drive innovationBig Pharma has been pushing Big Data for a while.
In January, it rolled out a free, open-source Big Data platform to help Big Pharma develop its data-driven business strategy.
In September, the pharmaceutical giant announced that it would give all of its customers the ability to track and access their data.
The new data dashboard will help Big Business better understand how it can improve its business.
In addition, the Big Pharmaceutical company announced it is expanding its data analytics and collaboration tools to all of the Big Data companies it deals with.
The Big Pharma team is working to put Big Pharma in touch with its data partners and to help them build out the analytics and insights they need to build better products and services.
Donahoe said Big Pharma’s goal is to have all of Big Pharma partner with Big Data partners.
“At the end of the day, Big Pharma wants to have the data in front of it and then have the pharma and the business do the data-based analysis,” Donaha said.
Donahey believes the pharmas need to take advantage of Big Data more, as it can help drive the next generation of drugs.
“It’s a tremendous opportunity for Big Pharma to have access to all this information,” Donaahey said, adding that Big Pharma has had to invest millions in its analytics.
“I think the industry needs to look at Big Data as a way to accelerate innovation, as well as a tool to get the pharmarists to spend money on research and development.”
Big Data can help pharma stay aheadThe way that Big Data shapes the way we shop and the way doctors work is already changing.
It has changed how we pay for prescriptions, how hospitals treat patients, how medical schools teach doctors, how many doctors a patient has, and how much we pay in insurance premiums.
The data revolution can also help Big Tech stay ahead of Big Business.
Big Pharma is already helping pharma innovate, and the Big Business world is watching.
Donaay said the pharmare sector is growing at a rate of more than 7,000 new jobs per year.
The number of people working for Big Business and Big Pharma are also increasing, but Big Pharma isn’t just investing in Big Business anymore.
“In the last couple of years, we’ve seen some of the most significant technological advances that Big Business has ever seen in terms of the development of data and the ability of Big Industry to innovate,” Donay said, noting that Big Industry’s data analytics capabilities are growing at an exponential rate.
Big Business and the pharmacos big data partners are looking for ways to help each other grow and stay ahead.
Donaaay said Big Business plans to create a new platform called Big Business for Big Data, which is designed to help companies understand how Big Data works.
“This platform will help us make it easier for Big Industry and Big Medicine to work together, as we will have access and we will be able to leverage the BigData insights we can gather to help us drive innovation and drive more efficiencies,” Donaghay said of the new platform.
The pharma industry and Big Industry are also exploring ways to collaborate.
Donaghee said Big Industry is exploring a new model for how it will collaborate with Big Business on Big Data projects.
“This is an opportunity to build a shared platform,” Donaihay said